300558 貝達藥業
按盤價 
68.780 +1.360 (+2.017%)
68.780 +1.360 (+2.017%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.505 | 7.438 | 6.892 | 3.091 | 8.804 |
| 總資產報酬率 ROA (%) | 1.509 | 4.355 | 4.081 | 2.051 | 6.661 |
| 投入資產回報率 ROIC (%) | 1.739 | 5.111 | 4.828 | 2.452 | 7.737 | 邊際利潤分析 |
| 銷售毛利率 (%) | 81.181 | 81.379 | 83.532 | 88.694 | 92.233 |
| 營業利潤率 (%) | 10.867 | 13.827 | 10.995 | 3.989 | 17.615 |
| 息稅前利潤/營業總收入 (%) | 13.131 | 14.875 | 14.724 | 11.072 | 17.416 |
| 淨利潤/營業總收入 (%) | 7.549 | 13.381 | 13.583 | 5.250 | 16.900 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 126.217 | 109.486 | 75.225 | -22.028 | 89.133 |
| 價值變動淨收益/利潤總額(%) | -43.937 | -10.394 | -4.244 | -23.545 | 4.094 |
| 營業外收支淨額/利潤總額(%) | -0.177 | -1.450 | 16.147 | -8.251 | -1.455 | 償債能力分析 |
| 流動比率 (X) | 0.774 | 0.663 | 0.846 | 0.823 | 1.861 |
| 速動比率 (X) | 0.584 | 0.506 | 0.665 | 0.646 | 1.531 |
| 資產負債率 (%) | 38.284 | 39.346 | 41.494 | 37.325 | 25.284 |
| 帶息債務/全部投入資本 (%) | 27.151 | 27.194 | 29.687 | 24.748 | -1.880 |
| 股東權益/帶息債務 (%) | 255.768 | 255.086 | 229.159 | 292.509 | -4,701.270 |
| 股東權益/負債合計 (%) | 158.846 | 151.645 | 138.352 | 164.239 | 287.637 |
| 利息保障倍數 (X) | 5.751 | 11.940 | 9.136 | 1.499 | 322.094 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 14.132 | 23.955 | 52.744 | 45.613 | 17.756 |
| 存貨周轉天數 (天) | 172.177 | 206.428 | 311.364 | 445.819 | 497.287 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 28/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
